Vycor Medical (VYCO) Shareholder's Equity Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.95% |
| Dec 31, 2025 | -11.59% |
| Sep 30, 2025 | -12.59% |
| Jun 30, 2025 | -14.16% |
| Mar 31, 2025 | -14.58% |
| Dec 31, 2024 | -52.41% |
| Sep 30, 2024 | -17.68% |
| Jun 30, 2024 | -17.43% |
| Mar 31, 2024 | -15.83% |
| Dec 31, 2023 | -18.84% |
| Sep 30, 2023 | -19.22% |
| Jun 30, 2023 | -21.73% |
| Mar 31, 2023 | -25.72% |
| Dec 31, 2022 | -29.49% |
| Sep 30, 2022 | -30.56% |
| Jun 30, 2022 | -36.20% |
| Mar 31, 2022 | -38.30% |
| Dec 31, 2021 | 72.30% |
| Sep 30, 2021 | -75.25% |
| Jun 30, 2021 | -108.66% |
| Mar 31, 2021 | -98.34% |
| Dec 31, 2020 | -197.49% |
| Sep 30, 2020 | -87.87% |
| Jun 30, 2020 | -58.20% |
| Mar 31, 2020 | -59.73% |
| Dec 31, 2019 | -271.40% |
| Sep 30, 2019 | -72.96% |
| Jun 30, 2019 | -52.75% |
| Mar 31, 2019 | -46.13% |
| Dec 31, 2018 | -37.72% |
| Mar 31, 2018 | -28.53% |
| Dec 31, 2017 | -71.75% |
| Sep 30, 2017 | -50.67% |
| Jun 30, 2017 | -16.87% |
| Mar 31, 2017 | 71.40% |
| Sep 30, 2016 | 28.89% |
| Jun 30, 2016 | 31.48% |
| Mar 31, 2016 | 34.27% |
| Dec 31, 2015 | 41.97% |
| Mar 31, 2015 | 83.18% |
| Dec 31, 2014 | 60.38% |
| Sep 30, 2014 | 25.37% |
| Jun 30, 2014 | -8.54% |